Atlas Trials

Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With RDEB.

Clinical trial NCT02984085 · TERMINATED

Trial details

NCT number
NCT02984085
Sponsor
Holostem s.r.l.
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Recessive Dystrophic Epidermolysis Bullosa
Start date
2017-01-30
Primary completion
2018-08-06
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.